Abbott Laboratories has been granted an FDA Emergency Use Authorization (EUA) for its COVID-19 rapid test that runs on its ID NOW platform.
Abbott’s COVID-19 ID NOW is said to identify and deliver positive test results in as little as five minutes and negative results within 13 minutes.
“Through the incredible work of teams across Abbott, we expect to deliver 50,000 COVID-19 tests per day to healthcare professionals on the front lines, where testing capabilities are needed most,” Abbott Rapid Diagnostics senior vice president Chris Scoggins said in a press release.
The compact rapid testing technology works by identifying even small instances of COVID-19 genomes and amplifying it so that the system can easily identify presence of the virus in a sample.
Watch how it works below.